Firehawk DES: proven fast healing from TARGET clinical programme
Chairpersons: M.B. Leon, W. Wijns
Objectives:
To understand the novel technology of an abluminal groove-filled biodegradable polymer DESTo learn about the up-to-date clinical data on the Firehawk stent
To discuss the potential benefits for our patients by using this novel technology
Lectures
Session objectives and FireHawk DES clinical programme
M.B. Leon
Shared cases from the TARGET all-comer trial
A. Baumbach
New release - Three-month OCT follow-up result from the randomised TARGET all-comer trial
W. Wijns
Updates on the five-year TARGET I randomised clinical trial and five-year TARGET II follow-up results
B. Xu